Lorne Infection & Immunity 2024
2024-02-14 08:00 - 2024-02-16 17:00 (America/New_York)
The Lorne Infection and Immunity Conference brings together scientists, students, health care and industry from multiple disciplines with a shared interest in infection and immunity research.
Registrations are open and abstracts are now being accepted.
ECR awards, subsidised student registrations, an amazing speaker list, networking and social events, and the return to our face-to-face meeting format combined with the advantages of online participation, mean participation is accessible to everyone and there is every reason to join in.
See below for links to register and for more information.
2024 THEMES
Host-pathogen interactions
Molecular basis of infectious diseases
Innate immunity
Adaptive immunity
Advances in immunotherapy vaccines and clinical translation
New solutions for antimicrobial resistance
Emerging infectious diseases and global health

8th AMR Conference
2024-03-06 08:00 - 2024-03-07 17:00 (America/New_York)
The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and specific challenges faced by the innovation ecosystem in bringing new antimicrobial treatments and diagnostics to the market.
The conference is the one-stop shop to catch up with the latest trends in the development of AMR products, by covering scientific, regulatory, financial and policy topics. Besides high-level talks, the conference is a great place to network and exchange views on innovative technologies, development paths and alternative business models with your peers. The conference also offers a partnering platform to facilitate interactions.
The 7th edition covered the whole innovation value chain, including scientific breakthrough, preclinical and clinical development, but also financial topics such as public funding for R&D, market incentive and investors’ perspective. Specific sessions were also dedicated to antimicrobials in the environment, diagnostics, antifungals, biologics and anti-tuberculosis drug combinations. There was a special focus on India and how the country is getting prepared to provide global solutions against AMR. Among other highlights were a start-up competition, hosted by the pharma-backed incubator INCATE, and a poster prize.

The AMR Conference is jointly organized by BEAM Alliance and bamconn GmbH.
The BEAM Alliance is one of the major supporting partners of the AMR Conference. Launched in June 2015, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance gathers more than 70 small and medium-sized European biotech and diagnostics companies committed to developing innovative products for fending off antibiotic-resistant pathogens. BEAM Alliance carries the voice of SMEs to support policies and incentives in antimicrobial research and development in Europe.
bamconn GmbH was established in November 2022 as a spin-off of BIOCOM AG and continues its entire event management as an independent company. It is built on more than 15 years of experience in the planning, organization and implementation of scientific events and exhibitions. The portfolio covers the entire spectrum from small workshops with 20 participants to multi-day international conferences for up to 2,000 people as well as exhibitions on the topic of bioeconomy throughout Europe. Customers for whom the bamconn team worked so far are companies, research institutions, associations and federal ministries as well as subordinate authorities and EU-funded projects.

Antimicrobial Resistance - Genomes, Big Data and Emerging Technologies
2024-03-13 08:00 - 2024-03-15 17:00 (America/New_York)
Antimicrobial resistance (AMR) is a major challenge in our globalised world, and tackling it will take the combined resources and effort of researchers working across different disciplines. Technical advances in recent years continue to expand our ability to collect vast amounts of genomic information on pathogens, and a wealth of data is being collected in epidemiological and surveillance studies, including on the socio-economic burden of AMR.
Our 4th conference in this series will bring together basic researchers, clinicians, computer scientists, and policymakers interested in pathogen genomics, epidemiology, surveillance, and machine learning to explore the recent advances and current challenges of the field.
This year’s programme will once again focus on genomic evidence and how to implement it in clinical practice and policy for AMR control. The meeting will highlight the advances in machine learning, AI and computational tools to predict AMR. We will also discuss how to build an international genomics infrastructure to tackle AMR and emerging lessons from other global public health issues.
This conference will be a hybrid meeting – with onsite or virtual attendance. In addition to invited talks, the programme will include short oral presentations selected from abstracts, posters, poster pitches and networking breaks for further discussion.

COMBINE Webinar | Development of Target Product Profiles for Antibiotics
2024-03-15 14:30 - 16:00 (Europe/Brussels)
Calling all #healthcare innovators! 📢 Don’t miss out on the IMI COMBINE project webinar discussing Target Product Profiles for #antibiotic development. Join industry leaders from CARB-X, Evotec, and GSK on March 15, 14:30 – 16:00 CET.
Dr. Erin Duffy, Chief of R&D of CARB-X, will be a panelist.
To register: https://limesurvey.biocom.de/index.php/191531?lang=en&newtest=Y
For more details on the webinar: https://amr-accelerator.eu/event/combine-webinar-on-developing-target-product-profiles-for-antibiotics/

Gordon Research Conference | Innovative Approaches in Antibacterial Research and Development to Fight the Antibiotic Resistance Crisis
2024-03-17 08:00 - 2024-03-22 17:00 (America/New_York)
The New Antibacterial Discovery and Development GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.

The antibiotic resistance crisis is among us, and with it, the urgent need to tackle this global health threat has never been greater. Yet each step in the discovery and development process, from target validation and inhibitor optimization to clinical trial design and product commercialization, poses formidable challenges. The New Antibacterial Discovery and Development GCR will turn these challenges into opportunities to promote interdisciplinary innovation while addressing the global need for more effective antibiotic therapies.
The conference will offer a forum where participants of all backgrounds and career stages explore solutions to current bottlenecks in antibacterial drug development, creating bridges between Academia, Industry, and Governments. Importantly, the meeting will provide early career researchers and trainees ample networking opportunities with highly experienced leaders in a positive and inclusive environment. We hope to see you in Ventura!

Novel Diagnostics for Infectious Diseases
2024-03-25 08:00 - 2024-03-26 17:00 (America/New_York)
This two-day meeting will delve into common challenges shared by diagnostics developers. Through presentations and panel discussions, attendees will explore topics such as Technologies and Challenges, Regulatory and Adoption Challenges, and Regulation and Policy Perspectives.
This workshop is co-organised and funded by Imperial College London’s Institute of Infection, B2B2B Network, London In Vitro Diagnostics Co-operative, NIHR Biomedical Research Centre, and DIAMONDS consortium. Funding is also provided by the UKRI IAA Healthy Society award and the Rosetrees Trust.

Betsy Wonderly Trainor, Alliance Director at CARB-X, will be a speaker during the “Funding innovative diagnostics: Lessons learnt and roadmap to future impact” session.

World Vaccine Congress
2024-04-01 08:00 - 2024-04-04 17:00 (America/New_York)
R&D + STRATEGIC PARTNERING FOR THE GLOBAL VACCINE INDUSTRY
The World Vaccine Congress is the largest, most established meeting dedicated to vaccines.
From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain where science, government and manufacturers all come together to create groundbreaking progress.

ECCMID 2024
2024-04-27 08:00 - 2024-04-30 17:00 (America/New_York)
Embrace the best of both worlds at ECCMID 2024 taking place 27-30 April 2024 in Barcelona, Spain! Engage in a cutting-edge medical congress, while experiencing the city’s irresistible charm. Barcelona offers the perfect fusion of knowledge and adventure.
ECCMID 2024 will follow the successful format introduced in 2022, offering a comprehensive hybrid congress. While we encourage the majority of our faculty, abstract presenters, and attendees, to participate on-site and benefit from the scientific, educational and networking experiences, provided by ECCMID, our seamless hybrid solution allows remote attendance for those unable to travel for any reason. Whether you come and join us in Barcelona, Spain or sign in online from your living room or office, you will be able to fully enjoy what ECCMID 2024 has to offer.

5th H3D Symposium
2024-05-21 08:00 - 2024-05-24 17:00 (America/New_York)
We are excited to announce that the 5th H3D Foundation Symposium will be taking place from 21 to 24 May 2024 at the Radisson Blu Mosi-Oa-Tunya Livingstone Resort in Zambia.
The symposium is a pinnacle event for H3D, following the success of the previous four symposia held in Cape Town and Livingstone.
The 5th H3D Symposium will be held at the prestigious Radisson Blu Mosi-Oa-Tunya Livingstone Resort in Zambia, providing a captivating backdrop near the magnificent Victoria Falls on the banks of the Zambezi River.
This symposium will focus on the theme “Emerging Treatments for Drug-Resistant Infections of Bacterial and Mycobacterial Origin,” addressing the pressing challenge of antimicrobial resistance (AMR).
What to expect:

Face-to-face exposure to more than 150 local, regional, and international delegates from tertiary institutions and the pharmaceutical industry, scientists, and researchers with a specific interest in TB, AMR & NTDS.
An innovative programme comprising instructional course lectures (ICLs), the latest research, keynote lectures, oral and rapid-fire sessions and ePosters.
Interaction between high-profile, distinguished international scientists and diverse participants, including postgraduate students and postdoctoral fellows.
A platform to present your latest research, product development, science, and capabilities to a global audience.
Provides your company and your products visibility.

Register to attend
Secure your spot and participate in this exceptional event by registering online today!

Boston Bacterial Meeting 2024
2024-06-03 08:00 - 2024-06-04 17:00 (America/New_York) | Boston University
The meeting will be held at Boston University at the George Sherman Union, 775 Commonwealth Ave, Boston.
The keynote address for BBM 2024 will be delivered by Dr. Joe Bondy-Denomy, UCSF. Joe Bondy-Denomy is an Associate Professor at UCSF. Dr. Bondy-Denomy earned his PhD from University of Toronto working in the lab of Alan Davidson. During this time, he studied the interactions between bacteriophages and Pseudomonas aeruginosa. He became especially interested in the role of bacterial CRISPR/Cas systems in defending against phages and the strategies phages use to overcome CRISPR/Cas systems. Specifically, he found that phages encode anti-CRISPR proteins that block the activity of CRISPR/Cas systems. He started his lab at UCSF in 2015 as a Sandler Faculty Fellow with a focus on understanding the interplay between bacterial CRISPR/Cas systems and phage anti-CRISPRs. He was promoted to Assistant Professor in 2017 and Associate Professor in 2020. His lab’s research has revealed fascinating insight into the interactions between bacteria and phages including discoveries of countless anti-CRISPR proteins, elucidation of the mechanisms through which CRISPR/Cas systems and anti-CRISPR proteins are regulated, and more recently investigation of novel mechanisms of phage defense and phage evasion. His lab has used understanding of CRISPR/Cas systems to improve methods for editing the genomes of bacteria and phages hoping that this will ultimately to support the development of phage therapies.
About BBM
BBM was founded in 1995 by two postdocs from Richard Losick’s lab at Harvard, Kit Pogliano and Karen McGovern, with the goal of bringing bacteriologists from the greater Boston area together to present their work and share ideas. BBM, now in its 30th year, has proven to be a vibrant meeting, attended not only by bacteriologists from the Boston area but from all over the country. Keeping with its roots, the conference is being planned and organized by a committee of students, postdocs, and other early career researchers. This year, the organizational committee is co-chaired by Molly Sargen, a graduate student in Sophie Helaine’s lab at Harvard Medical School, and Laurent Dubois, a graduate student in Tom Bernhardt’s lab at Harvard Medical School.

BIO San Diego
2024-06-03 08:00 - 2024-06-06 17:00 (America/New_York)
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over 20,000 industry leaders from across the globe.
Whether you work at a public pharmaceutical company, biotech startup, academia, non-profits, and government or are a researcher, business development professional or investor, BIO is where you’ll make valuable connections and build relationships. Our proprietary BIO One-on-One Partnering™ match-making platform—included in the Premier Access registration package—allows you to find potential partners, schedule and accept meetings.

ASM Microbe
2024-06-13 08:00 - 2024-06-17 17:00 (America/New_York)
Scientific Breakthroughs Begin at ASM Microbe

Join us in Atlanta, June 13-17, 2024!
As the world’s largest microbial sciences conference, ASM Microbe is the best place to showcase your research, engage with global leaders and forge new connections with scientists, researchers and educators, just like you. Dive deep into groundbreaking discoveries across 8 scientific tracks and tailor your experience with our unique meeting-within-a-meeting format. Whether you immerse yourself in the broader conference or focus on your specialty, an unparalleled experience awaits!

Global Health Security Conference 2024
2024-06-18 08:00 - 2024-06-21 17:00 (America/New_York)
Welcome to our third Global Health Security conference, which returns to Sydney, Australia, in June 2024! Even as the COVID-19 pandemic remains ongoing, the health challenges people confront from a changing climate, zoonotic pathogens, microbial resistance, conflict, and the social, political and economic determinants of health that exacerbate poor health, exposure to disease, and an inability to access affordable healthcare services, can seem insurmountable at times. Yet by working collaboratively to bring multiple stakeholders from across disciplines and professions where we can share learnings, research, policy innovations and solutions, we can build a safer and healthier world for all. Join us in Sydney to be part of this important dialogue!

World AMR Congress 2024
2024-09-05 08:00 - 2024-09-06 17:00 (America/New_York) | Pennsylvania Convention Center, Philadelphia, PA
Since 2015, the World Anti-Microbial Resistance Congress has been the go-to conference globally for all stakeholders in the AMR space to meet, brainstorm ideas and formulate initiatives that can effectively tackle antimicrobial resistance.
Join us for the World AMR Congress and get full access to the Disease Prevention & Control Summit co-located at the Pennsylvania Convention Center on September 5-6

World Cancer Congress
2024-09-17 08:00 - 2024-09-19 17:00 (America/New_York) | Geneva, Switzerland
The World Cancer Congress aims to strengthen the participants’ actions and impact on national, regional and international scales through a multidisciplinary programme featuring the latest successful cancer prevention, diagnosis, treatment and care interventions.
The World Cancer Congress is an initiative of the Union for International Cancer Control (UICC) – which was recognised with Membership Engagement Award – and supports the organisation’s mission: ‘to both unite and support the cancer community in its efforts to reduce the global cancer burden, promote greater equity and ensure that cancer control remains a priority on the global health and development agenda’.
The upcoming edition will however be hosted in UICC’s hometown, Geneva in Switzerland, on 17-19 September 2024, at the International Conference Centre Geneva (CICG). UICC member organisations from across Europe will be joining in as co-hosts.

ESCMID/ASM 2024
2024-09-17 08:00 - 2024-09-20 17:00 (America/New_York)
The 2024 ESCMID/ASM Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance will take place in Porto, Portugal on September 17-20, 2024. Make sure to save the date.

Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by national and international bodies. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements for antimicrobial drug development to address antimicrobial resistance.

8th World One Health Congress
2024-09-20 08:00 - 2024-09-23 17:00 (America/New_York) | Cape Town, South Africa
The global One Health Community is organizing the 8th World One Health Congress in Cape Town
20 September – 23 September 2024

The Congress foresees four days of an outstanding, exceptional and forward-thinking agenda, which includes parallel tracks addressing one health science, antimicrobial agents and resistance, and science policy interface, amongst others.
It will enable discussing major One Health challenges, as well as sharing research data and policy developments. Above all, it will provide a great opportunity to look at global One Health science and policy through an African lens. Through an open call for abstracts, notable work from distinguished scientists and opinion leaders will be disseminated at the world’s largest forum dedicated to advancing the One Health agenda and community.
Building on the success of the 7th World One Health Congress in 2022 in Singapore, it will bring together One Health stakeholders, from science researchers, policymakers, representatives of international institutions, civil society to the private sector from around the world.

World Health Summit 2024
2024-10-13 08:00 - 2024-10-15 17:00 (America/New_York) | Berlin, Germany
The World Health Summit is the unique international strategic forum for global health. Held annually in Berlin, it brings together stakeholders from politics, science, the private sector, and civil society from around the world to set the agenda for a healthier future by inspiring innovative solutions for better health and well-being for all.
The World Health Summit 2024 takes place from October 13-15 in Berlin, Germany and online under the theme “Building Trust for a Healthier World”. It stands under the patronage of German Chancellor Olaf Scholz and Director-General of the World Health Organization (WHO) Tedros Adhanom Ghebreyesus.

IDWeek 2024
2024-10-16 08:00 - 2024-10-19 17:00 (America/New_York)
IDWeek is the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, the Pediatric Infectious Diseases Society and the Society of Infectious Diseases Pharmacists. Come discover the science at the premier forum for ID health professionals of varied backgrounds and collaborate, connect and learn from each other’s expertise for the improvement of patient care and public health. Join your ID community Oct. 16-19, 2024, in sunny Los Angeles.

11th NIKKEI FT Communicable Diseases Conference
2024-10-22 08:00 - 2024-10-23 17:00 (America/New_York) | Tokyo, Japan
Nikkei Inc. has been organizing the annual Nikkei FT Communicable Diseases Conference since 2014, gathering internationally renowned experts in the field; representatives of the private sector, academia and high-ranking government officials responsible for health, both within and outside Japan. The conference has been advocating action plans domestically and internationally through the global media outlets of the Nikkei Group.

World Vaccine Congress Europe 2024
2024-10-29 08:00 - 2024-10-31 17:00 (America/New_York)
The World Vaccine Congress Europe is the largest and most established European meeting on vaccine R&D

FT Global Pharma and Biotech Summit 2024
2024-11-05 08:00 - 2024-11-07 17:00 (America/New_York) | London, UK
The world of life sciences is in a period of relentless disruption. Advances in technology are transforming research and development. Innovative treatments such as mRNA vaccines and cell therapies are reshaping healthcare as we know it. Meanwhile, companies face the challenge of bringing products to market in an unsettled regulatory environment.
The Global Pharma and Biotech Summit is the essential annual event for you to stay on top of the latest trends and innovations in life sciences. Industry leaders and experts will discuss what’s new in areas such as drug discovery, clinical trials, market access and patient engagement.

BIO 2025
2024-12-11 08:00 - 17:00 (America/New_York) | Boston Convention Center, 415 Summer St, Boston, MA, 02210, United States
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.
Whether you work at a public pharmaceutical company, biotech startup, academia, non-profits, and government or are a researcher, business development professional or investor, BIO is where you’ll make valuable connections and build relationships. Our proprietary BIO One-on-One Partnering™ match-making platform—included in the Premier Access registration package—allows you to find potential partners, schedule and accept meetings.

27th PACCARB Public Meeting
2025-01-28 08:00 - 2025-01-29 17:00 (America/New_York) | London, UK
The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) provides advice, information, and recommendations to the U.S. Secretary of Health and Human Services (HHS Secretary). The council supports and evaluates U.S. government activities focused on fighting antimicrobial resistance (AMR) in human health, animal health, and environmental health. Using this One Health approach, members of the PACCARB have expertise from a range of backgrounds, including academia, industry, public health, advocacy, veterinary, and agricultural production.
The PACCARB was established under Executive Order 13676 and included in the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAIA). Since 2019, the President has given authority to the HHS Secretary as the primary recipient of PACCARB recommendations. Additional information on the authority and activities of the PACCARB can be found on the About Us page in the charter.
As a federal advisory committee, the PACCARB looks to engage with the public and all AMR stakeholders. The council holds several public meetings every year both in-person and live streamed on the HHS.gov website. These meetings are open to anyone with an interest in combating AMR. See how to get involved!

To provide a public comment or opinion to the council, send an email to CARB@hhs.gov or check out the Meetings page for more information.
Public meetings are a great venue for industry start-ups to join the Innovation Spotlight session to share their advancements and challenges. Be sure to register in advance.
If you would like to share your experience as a patient or person impacted by antimicrobial resistant bacteria or fungi, we would love to hear your story. Send us an email at CARB@hhs.gov.
For anyone wanting to stay connected with PACCARB updates and upcoming meetings, please email CARB@hhs.gov with the subject line “Friends of PACCARB” to be added to our mailing list.

Antimicrobial Chemotherapy Conference
2025-02-04 08:00 - 2025-02-05 17:00 (America/New_York) | VIRTUAL EVENT
This open-access, virtual conference is jointly organised by BSAC and GARDP. For ACC2025, the collaborating organisations are CEPID-ARIES and Fiocruz. This conference is RCPath CPD accredited (8 credits).

IPLS x HLA Biotech & Life Sciences Conference
2025-02-20 08:00 - 17:00 (America/New_York)
IPLS and HLA are excited to host a biotech-themed evening at Barrister’s Hall. We will host panels on intellectual property in the life sciences and the state of health law today. Please join us for our first Biotech Conference!

9th AMR Conference
2025-02-25 08:00 - 2025-02-26 17:00 (America/New_York) | Basel, Switzerland
The AMR Conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and specific challenges faced by the innovation ecosystem in bringing new antimicrobial treatments and diagnostics to the market.
The conference is the one-stop shop to catch up with the latest trends in the development of AMR products, by covering scientific, regulatory, financial and policy topics. Besides high-level talks, the conference is a great place to network and exchange views on innovative technologies, development paths and alternative business models with your peers. The conference also offers a one-to-one partnering to facilitate interactions.
Once more, the 9th edition will cover the whole innovation value chain, including scientific breakthrough, preclinical and clinical development, but also financial topics such as public funding for R&D, market incentive and investors’ perspective. Specific sessions will be dedicated to access, manufacturing and financing. There will also be a focus on One Health and on the growing threat of sexually transmitted diseases. Among other highlights, there will be again a start-up pitch, hosted by the pharma-backed incubator INCATE, and a presentation of scientific posters.
The AMR Conference is jointly organized by BEAM Alliance and bamconn GmbH.
The BEAM Alliance is one of the major supporting partners of the AMR Conference. Launched in June 2015, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance gathers more than 70 small and medium-sized European biotech and diagnostics companies committed to developing innovative products for fending off antibiotic-resistant pathogens. BEAM Alliance carries the voice of SMEs to support policies and incentives in antimicrobial research and development in Europe.

Microbiome Times Partnering Forum
2025-03-18 08:00 - 2025-03-19 17:00 (America/New_York)
Meet Dealmakers from biotech, VCs, consumer care and pharma
This two-day event expects to see over 50 expert speakers and over 500 delegates descend on Brussels, 18-19 March to uncover the latest in microbial product innovation. Organised by Microbiome Times Magazine, the leading industry trade journal. the MT Partnering Forum will explore the industry’s latest trends, scientific advancements, challenges, and opportunities to accelerate the development of novel microbial-based products.
Free-to-attend for start-ups, academic innovators, investors and healthcare companies, Microbiome Times Forum provides attendees with the opportunity to meet their next collaborator, partner or customer by scheduling over 30 one-to-one meetings through our tailor-made partnering platform,

ESCMID Global 2025
2025-04-11 08:00 - 2025-04-15 17:00 (America/New_York) | Vienna, Austria
Explore Vienna with ESCMID Global 2025 and grab the opportunity to immerse yourself in the latest topics of infectious diseases and clinical microbiology in this former imperial city. Join leading experts, discover cutting-edge research, and network with peers in a dynamic setting at Messe Wien Exhibition & Congress Center. Learn more about the historic setting of the next instalment of ESCMID Global, 11–15 April 2025.

The 2nd Asia Pacific Conference on Point of Care Testing for Infectious Diseases
2025-06-19 08:00 - 2025-06-21 17:00 (America/New_York)
The Rapid Point of Care Research Consortium for Infectious Diseases (RAPID) and ASHM Health are collaborating to present the 2nd Asia Pacific Conference on Point of Care Testing for Infectious Diseases (POC 2025) in Bangkok, in partnership with Drs Rossaphorn Kittiyawamarn & Nittaya Phanuphak as the local POC 2025 convenors.
This partnership builds on the success of their previous endeavours to enhance access to rapid diagnostic tools, particularly for infectious diseases such as HIV/AIDS, viral hepatitis, cervical cancer, sexually transmitted infections, tuberculosis, malaria, antimicrobial resistance, and other key infections.The conference will bring together leading experts, including from community, healthcare professionals, and researchers from across the Asia-Pacific region.

The conference aims to showcase innovations in point-of-care testing, discuss strategies for implementation, and address challenges related to equitable access and healthcare integration. This collaboration fosters a comprehensive approach to tackling infectious diseases, improving diagnostic capabilities, and enhancing patient care in diverse settings across the region.
